Sutent News
Most Popular Sutent Story
Pfizer's Sutent strategy pays off
Sutent performs for Pfizer strategy-wise--and in a newly released trial. First, the strategy--let's call it Never Give In, Never Never. To persuade the U.K.'s National Institute for Clinical Read more...
Latest Headlines
- April 13, 2011
- April 11, 2011
- January 25, 2011
- December 27, 2010
- September 28, 2010
- August 24, 2010
- April 23, 2010
- March 12, 2010
- March 8, 2010
- August 26, 2009
- July 1, 2009
- June 25, 2009
- June 2, 2009
- March 12, 2009
- February 4, 2009
- December 1, 2008
- August 7, 2008
- July 15, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
